Salt bridges:
B:K.54,
B:K.54,
B:R.61,
B:K.127,
B:R.134
pi-Cation interactions:
B:R.65
6 x
MG:
MAGNESIUM ION(Non-functional Binders)(Non-covalent)
MG.2:
1
residues within 4Å:
Chain A:
K.164
No protein-ligand interaction detected (PLIP)
MG.3:
1
residues within 4Å:
Chain A:
E.7
3 PLIP interactions:
1 interactions with chain A,
2 Ligand-Water interactions
Metal complexes:
A:E.7,
H2O.1,
H2O.4
MG.4:
3
residues within 4Å:
Chain A:
R.90,
E.91,
E.94
5 PLIP interactions:
1 interactions with chain A,
4 Ligand-Water interactions
Metal complexes:
A:E.94,
H2O.2,
H2O.3,
H2O.8,
H2O.11
MG.7:
1
residues within 4Å:
Chain B:
K.164
No protein-ligand interaction detected (PLIP)
MG.8:
1
residues within 4Å:
Chain B:
E.7
3 PLIP interactions:
1 interactions with chain B,
2 Ligand-Water interactions
Metal complexes:
B:E.7,
H2O.12,
H2O.15
MG.9:
3
residues within 4Å:
Chain B:
R.90,
E.91,
E.94
5 PLIP interactions:
1 interactions with chain B,
4 Ligand-Water interactions
Metal complexes:
B:E.94,
H2O.13,
H2O.14,
H2O.19,
H2O.22
2 x
EZ5:
~{N}-[(2~{S})-2-[(1~{E},3~{R},4~{S},8~{R},9~{R},10~{R},11~{S},14~{S})-14-(methoxymethyl)-3,10-dimethyl-8-[(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(2-methylbut-3-en-2-yloxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,9-bis(oxidanyl)-6-tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dienyl]propyl]ethanamide(Non-covalent)
Visser, E.J. et al., Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer. To Be Published
